Study On Lung-Infecting Bacterial Enzyme Suggests New Approach To Cystic Fibrosis Treatment

Researchers at the University of Pennsylvania School of Medicine have discovered that an enzyme produced by lung-infecting bacteria further shuts down a protein that is defective in cystic fibrosis patients. The disruption to this protein that conveys ions from lung cells to airways causes thick mucus to buildup inside the lung. The finding suggests a new therapeutic target for treating lung infections in some cystic fibrosis (CF) patients.

Lung infection, facilitated by CF mutations, is the main cause of death in CF patients. This bacterial component to CF now helps explain why the severity of CF symptoms did not match the pathological effect of the CF mutation alone. The study was published this month in the Proceedings of the National Academy of Sciences.The research, conducted by Zhe Lu, MD, PhD; Yajamana Ramu, PhD; and Yanping Xu, MD, PhD, of the Department of Physiology, shows that the bacterial enzyme, called sphingomyelinase (SMase), disables a protein in lungs called CFTR, for cystic fibrosis transmembrane conductance regulator. SMase is made by the bacteria that cause pneumonia, some anthrax-causing bacteria, and bacteria that cause opportunistic infections in CF and AIDS patients.In healthy lungs, CFTR allows the passage of chloride ions (and accompanying water) into airways, creating a thin layer of fluid to keep airways clear. However, SMase, secreted by certain respiratory tract bacteria, breaks down lipids surrounding CFTR and thereby suppresses CFTR's chloride-passing function. To make matters worse, the products of the lipid breakdown are also known to trigger inflammation and cell death.Together, these facts compellingly suggest that SMase plays a critical role in the heretofore mysterious pathogenesis of lung injury in CF patients. They also present a new paradigm for treating CF. Specific inhibitors against the enzyme, in conjunction with current antibiotic treatments and supportive measures, might be a viable near-term approach to improving length and quality of life for many CF patients, before CF gene therapy becomes a reality.The Penn research team demonstrated the disruptive action of SMase in frog oocytes (egg cells) engineered to place CFTR in their membrane. These oocytes are an experimental tool that allows the researchers to assess the flow of ions across the membrane by measuring electrical current. The researchers found that direct exposure of the CFTR-containing oocytes to SMase of Staphylococcus aureus and Bacillus anthracis bacteria shuts off the electrical current passing through not only the normal, but also the CF-causing mutant CFTR.The next step for the research team is to develop specific inhibitors against the bacterial SMase and test the idea in an animal model. (Source: Proceedings of the National Academy of Sciences : University of Pennsylvania : May 2007.)


calendar icon Article Date: 16/5/2007

 

Related Articles:


Website Tools

Sign up for free newsletter Sign up for free newsletters
News RSS feeds Subscribe to RSS feeds
Discuss on Forum Discuss on Forum

 

Article Tools

Email this article to a friend Email this article to a friend
Share on Twitter Share on Twitter
Share on Facebook Share on Facebook
Share on StumbleUpon Share on StumbleUpon
Print this article Print this article
Bookmark this page Bookmark this page (press Ctrl+D)

 

Article Comments

Add your comment to this article





 Change Code


 Enter the above security Code

User-generated Content Guidelines

Rate this article

Current Sponsors
Proudly brought to you by
Proudly brought to you by
Sponsors Logos
Accreditation and Awards
Accreditations and Awards
Our site has been approved by the HealthInsite Editorial Board to be a HealthInsite information partner site PANDORA is a digital archive dedicated to the preservation of and long term access to Australian online electronic publications of national significance No. 1 Website in the Hitwise Top 10 Website Award in recognition of outstanding performance WAITTA Winner 2008 Online 2005 Finalist in the Secrets of Australian IT Innovation Awards Australian Prime Minister's awards for excellence in community business partnerships 2004
2004 Finalist in the Secrets of Australian IT Innovation Awards
Current Sponsors

Virtual Medical Centre

Australia’s leading source for trustworthy medical information written by health professionals.

Please be aware that we do not give advice on your individual medical condition,
if you want advice please see your treating physician.

Information on this site must be discussed with your treating doctor.

Virtual Medical Centre © 2002 - 2010 | Privacy Policy Last updated 6 Sep 2010

News RSS feedsRSS News feed

For Banner Advertising
MediaSmart

Website and videos by
Titan Interactive, Website and Web Design Perth Australia

^ Back to Top